Perrigo Company plc (FRA:PIG)

Market Cap	1.98B -22.9%
Revenue (ttm)	3.63B -4.2%
Net Income	-1.52B
EPS	-11.13
Shares Out	n/a
PE Ratio	n/a
Forward PE	6.79
Dividend	0.99 (6.90%)
Ex-Dividend Date	Aug 28, 2026

Volume	500
Open	14.40
Previous Close	13.95
Day's Range	14.40 - 14.40
52-Week Range	7.82 - 18.73
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2026

About Perrigo Company

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pai...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1887
• Employees: 8,100
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PIG

Financial Performance

In 2025, Perrigo Company's revenue was $4.25 billion, a decrease of -2.75% compared to the previous year's $4.37 billion. Losses were -$1.43 billion, 729.7% more than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error